- Home
- TOVX vs NCLH Comparison
TOVX vs NCLH Comparison
Compare TOVX & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOVX | NCLH |
|---|---|---|
| Founded | 2001 | 1966 |
| Country | United States | United States |
| Employees | 16 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 7.9B |
| IPO Year | 2012 | 2011 |
Fundamental Metrics
Financial Performance| Metric | TOVX | NCLH |
|---|---|---|
| Price | $0.23 | $14.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 17 |
| Target Price | $1.00 | ★ $24.76 |
| AVG Volume (30 Days) | 411.4K | ★ 13.7M |
| Earning Date | 05-13-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.07 | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | N/A | ★ $5,396,175,000.00 |
| Revenue This Year | N/A | $9.96 |
| Revenue Next Year | N/A | $6.60 |
| P/E Ratio | ★ N/A | $19.89 |
| Revenue Growth | N/A | ★ 10.71 |
| 52 Week Low | $0.16 | $14.10 |
| 52 Week High | $0.86 | $26.09 |
Technical Indicators
Market Signals| Indicator | TOVX | NCLH |
|---|---|---|
| Relative Strength Index (RSI) | 49.65 | 31.31 |
| Support Level | $0.22 | N/A |
| Resistance Level | $0.26 | $21.04 |
| Average True Range (ATR) | 0.01 | 0.48 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 46.25 | 15.75 |
Price Performance
Historical ComparisonAbout TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
About NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 75,000). It operates 35 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet after the pandemic as of May 2022. With 16 passenger vessels on order among its brands through 2037, representing 43,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.